Softlab9 Technologies Inc. (CSE: SOFT; Frankfurt: APO2; OTC: SOFSF) ('Softlab9' or the 'Company'), provides shareholders with a corporate update.
Softlab9 continues to perform its due diligence process on its acquisition (the 'Transaction') of Clean Go Green Go Inc. ('CleanGo GreenGo'). This process has taken more time than expected due to the changing market conditions and latest developments at CleanGo GreenGo and its partners. The Company expects to complete a definitive agreement in the near future as it awaits the completion of CleanGo GreenGo audits. Once completed, Softlab9 expects the transaction to close quickly. The Transaction is subject to all required regulatory approval, including approval of the Canadian Securities Exchange.
About 'Clean Go Green Go'
CleanGo GreenGo is an FDA and Health Canada approved Manufacturer of Green, Non-Toxic, and Biodegradable suite of cleaning products for industrial, commercial and consumer markets. CleanGo GreenGo, also manufactures hand sanitizer gel which is sold throughout the USA and Canada. CleanGo's products have been tested in 2015 in the USA to kill the human coronavirus. CleanGo's products are sold ' various online platforms, including Amazon, as well as through distribution in retail, wholesale, and government agencies. CleanGo GreenGo utilizes a Patent Pending IP. The Patent was filed with the United States Patent and Trademark Office in February 2020 and currently holds a Patent Pending Status.
Forward-looking Information
This news release contains forward-looking statements and forward-looking information (collectively, 'forward-looking statements') within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements in this presentation that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations, and orientations regarding the future, including without limitation, statements related to the frequency of shipments of CleanGo GreenGo concentrate to CBIO Brand Distribution International Inc., due diligence on Orient Gene Antigen Test kits, definitive agreements with Emergence Technology and HEG and the Company's prospect of success in executing its proposed plans, including its plans to complete the acquisition of CleanGo GreenGo and the prospects for CleanGo GreenGo's business. Forward-looking statements can often be identified by words such as 'will', 'plans', 'expects', 'may', 'intends', 'anticipates', 'believes', proposes' or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements are based on certain assumptions by management regarding the Company, including, without limitation, the Company's ability to enter definitive agreements with HEG and Emergence Technology, acquire CleanGo GreenGo and obtain required regulatory approvals and the timing thereof. Actual results could differ from those projected in any forward-looking statements due to numerous factors including, risks and uncertainties relating to the inability of the Company, to, among other things, obtain any required governmental, regulatory or stock exchange approvals, permits, consents or authorizations required to execute its proposed business plans, and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the Company's operations may also adversely affect the future results or performance of the Company. The Company can provide no guarantee that it will be successful in completing the acquisition of CleanGo GreenGo. Investors are cautioned that forward looking statements are not guarantees of future performance or events and, accordingly are cautioned 4829-1788-8719, v. 3 not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forwardlooking statements included in this news release are made as of the date hereof and the Company does not intend to update or revise any forward-looking statements, except as expressly required by law.
Contact:
Tel: (778) 240-772
Email: psearle@citygatecap.com
SOFTLAB9 TECHNOLOGIES 
